Literature DB >> 19549989

Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.

Bénédicte Dumont1, Dominique Lasne, Chantal Rothschild, Maxime Bouabdelli, Véronique Ollivier, Claire Oudin, Nadine Ajzenberg, Bernard Grandchamp, Martine Jandrot-Perrus.   

Abstract

The glycoprotein VI (GPVI)/FcRgamma complex is a key receptor for platelet activation by collagen. We describe, for the first time, 2 genetic abnormalities in one patient. This 10-year-old girl presented ecchymoses since infancy, a prolonged bleeding time despite a normal platelet count and no antiplatelet antibodies. Collagen-induced platelet activation was null, whereas GPVI quantification by flow cytometry evidenced an incomplete deficiency. Immunoblotting showed an abnormal migration of residual GPVI, and no FcRgamma defect. GPVI DNA sequencing revealed (1) an R38C mutation in exon 3 of one allele and (2) an insertion of 5 nucleotides in exon 4 of the other allele, leading to a premature nonsense codon and absence of the corresponding mRNA. Introduction of the R38C mutation into recombinant GPVI-Fc resulted in abnormal protein migration and a loss of collagen binding. Thus, this composite genetic GPVI deficiency and dysfunction cause absence of platelet responses to collagen and a mild bleeding phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549989     DOI: 10.1182/blood-2009-03-213504

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  Extracellular matrix proteins in hemostasis and thrombosis.

Authors:  Wolfgang Bergmeier; Richard O Hynes
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  Greater collagen-induced platelet aggregation following cyclooxygenase 1 inhibition predicts incident acute coronary syndromes.

Authors:  Rehan Qayyum; Diane M Becker; Lisa R Yanek; Nauder Faraday; Dhananjay Vaidya; Rasika Mathias; Brian G Kral; Lewis C Becker
Journal:  Clin Transl Sci       Date:  2014-07-25       Impact factor: 4.689

3.  Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice.

Authors:  Yuhang Zhou; Shaji Abraham; Pierrette Andre; Leonard C Edelstein; Chad A Shaw; Carol A Dangelmaier; Alexander Y Tsygankov; Satya P Kunapuli; Paul F Bray; Steven E McKenzie
Journal:  Blood       Date:  2015-10-29       Impact factor: 22.113

Review 4.  Platelet receptor signaling in thrombus formation.

Authors:  David Stegner; Bernhard Nieswandt
Journal:  J Mol Med (Berl)       Date:  2010-11-07       Impact factor: 4.599

5.  Platelet ITAM signaling is critical for vascular integrity in inflammation.

Authors:  Yacine Boulaftali; Paul R Hess; Todd M Getz; Agnieszka Cholka; Moritz Stolla; Nigel Mackman; A Phillip Owens; Jerry Ware; Mark L Kahn; Wolfgang Bergmeier
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

6.  Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel.

Authors:  Ban B Dawood; Gillian C Lowe; Marie Lordkipanidzé; Danai Bem; Martina E Daly; Mike Makris; Andrew Mumford; Jonathan T Wilde; Steve P Watson
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

7.  Glycoprotein VI Blockade: Not Just Targeting Collagen Anymore?

Authors:  Shuchi Gupta; Lawrence F Brass
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-08-26       Impact factor: 8.311

8.  The landscape of human STR variation.

Authors:  Thomas Willems; Melissa Gymrek; Gareth Highnam; David Mittelman; Yaniv Erlich
Journal:  Genome Res       Date:  2014-08-18       Impact factor: 9.043

Review 9.  Inherited platelet disorders: toward DNA-based diagnosis.

Authors:  Claire Lentaigne; Kathleen Freson; Michael A Laffan; Ernest Turro; Willem H Ouwehand
Journal:  Blood       Date:  2016-04-19       Impact factor: 25.476

Review 10.  Targeting GPVI as a novel antithrombotic strategy.

Authors:  Robert K Andrews; Jane F Arthur; Elizabeth E Gardiner
Journal:  J Blood Med       Date:  2014-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.